Elsevier

Regulatory Peptides

Volume 48, Issues 1–2, 20 October 1993, Pages 251-256
Regulatory Peptides

Identification of insulin-like growth factor (IGF) and glucose transporter-1 and -3 mRNA in CNS tumors

https://doi.org/10.1016/0167-0115(93)90354-BGet rights and content

Abstract

Glucose metabolism is increased in CNS tumors and correlates with malignant grade. We have previously investigated the role of IGFs in regulating CNS tumor growth and metabolism. In the present study we examined total cellular RNA from human CNS tumors for the presence for glucose transporter (Glut) and IGF mRNA.

Human meningiomas and gliomas were frozen in liquid nitrogen at the time of surgery and then stored at −80°C. Total cellular RNA was prepared by acid-guanidinium phenol-chloroform extraction and 20 μg of RNA was loaded for agarose-formaldehyde gel electrophoresis and transfer. RNA intergrity in 5 meningiomas and 2 gliomas was confirmed by ethidium bromide staining of 28S and 18S ribosomal RNA and hybridization with a cDNA probe for β-actin. For analysis, membranes were hybridized to radioactively labeled human Glut-1, Glut-3, IGF-I, and IGF-II cDNA probes, and mRNA transcripts were identified by autoradiography. All 7 tumors expressed Glut-1 and Glut-3 mRNA and Glut-3 appeared to be more abundant in meningiomas. IGF-II mRNA was detected in 2 of 6 meningiomas and in both gliomas.

IGFs may play an important role in the regulation of glucose metabolism in CNS tumors. IGFs and specific glucose transporters may prove useful as markers of malignancy and potential targets for future therapy.

References (40)

  • G.I. Bell et al.

    Molecular biology of mammalian glucose transporters

    Diabetes Care

    (1990)
  • H. Fukumoto et al.

    Characterization and expression of human HepG2/erythrocyte glucose-transporter gene

    Diabetes

    (1988)
  • J. Flier et al.

    Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man

    J. Clin. Invest.

    (1987)
  • R. Kalaria et al.

    The glucose transporter of the human brain and blood brain barrier

    Ann. Neurol.

    (1988)
  • M. Birnbaum et al.

    Cloning and characterization of a cDNA encoding the rat brain glucose transporter protein

  • M. Kasanacki et al.

    Immunocytochemical localization of the glucose-transport protein in mammalian brain capillaries

    Histochem. J.

    (1989)
  • D. Gerhart et al.

    Neurons and microvessels express brain glucose transporter protein GLUT 3

  • M. Raizada

    Insulin and IGF-I actions on the brain

  • H. Werner et al.

    Developmental regulation of rat brain/Hep G2 glucose transporter gene expression

    Mol. Endocrinol.

    (1989)
  • H. Werner et al.

    Regulation of rat brain/Hep G2 glucose transporter gene expression by insulin and insulin-like growth factor-I in primary cultures of neuronal and glial cells

    Endocrinology

    (1989)
  • Cited by (19)

    • Expression of glucose transporters in cancers

      2013, Biochimica et Biophysica Acta - Reviews on Cancer
      Citation Excerpt :

      Parente et al. [45] have observed expression of GLUT3 in all cases of melanocytic nevi, Spitz nevi, and primary cutaneous malignant melanomas. Overexpression of GLUT3 in relation to relevant non-cancerous tissue was observed in the case of carcinomas: brain [51], breast [52], gastric [47,53], head and neck [54,55], lung [53,56,57], meningiomas [58], oral squamous cell carcinoma [40], and ovarian [53]. It is to note that expression of GLUT3 is potential prognostic marker for oral squamous cell carcinoma [40].

    View all citing articles on Scopus
    View full text